Wesley D Kufel
Overview
Explore the profile of Wesley D Kufel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
378
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kufel W, MacDougall C, Covington E, Gallagher J, Seabury R, Steele J
Open Forum Infect Dis
. 2025 Feb;
12(2):ofaf074.
PMID: 39990631
No abstract available.
2.
Shields R, Abbo L, Ackley R, Aitken S, Albrecht B, Babiker A, et al.
Lancet Infect Dis
. 2024 Dec;
PMID: 39701120
Background: Ceftolozane-tazobactam and ceftazidime-avibactam are preferred treatment options for multidrug-resistant Pseudomonas aeruginosa infections; however, real-world comparative effectiveness studies are scarce. Pharmacokinetic and pharmacodynamic differences between the agents might affect clinical...
3.
Lam H, Parsels K, Steele J, Kufel W, Andrew R, Miller C, et al.
J Pharm Pract
. 2024 Nov;
38(2):221-224.
PMID: 39562507
No abstract available.
4.
Kufel W, Hanrahan K, Seabury R, Parsels K, Gallagher J, MacDougall C, et al.
Open Forum Infect Dis
. 2024 Nov;
11(11):ofae641.
PMID: 39529938
Background: It is unknown whether ChatGPT provides quality responses to infectious diseases (ID) pharmacotherapy questions. This study surveyed ID pharmacist subject matter experts (SMEs) to assess the quality of ChatGPT...
5.
Kufel W, Kufel J
Am J Health Syst Pharm
. 2024 Sep;
82(4):211-222.
PMID: 39324594
Purpose: The purpose of this review is to describe important considerations with local antimicrobial therapies such as locks, beads, and cement for adjunctive infection management or prevention. Summary: Local delivery...
6.
Dressler A, Seabury R, Darko W, Kufel W, Steele J, Kelly C, et al.
J Pharm Pract
. 2024 Aug;
38(1):128-140.
PMID: 39165184
Many Postgraduate Year One (PGY1) Pharmacy residencies provide research training however, details of this training are not well described. Publication rates have been utilized to assess residency research learning experiences....
7.
Kufel W, Priyank K
Antimicrob Agents Chemother
. 2024 Jul;
68(8):e0070024.
PMID: 39037242
No abstract available.
8.
Cluck D, Chastain D, Murray M, Durham S, Chahine E, Derrick C, et al.
Pharmacotherapy
. 2024 Jun;
44(5):354-359.
PMID: 38853605
Treatment options are currently limited for persons with HIV-1 (PWH) who are heavily treatment-experienced and/or have multidrug-resistant HIV-1. Three agents have been approved by the U.S. Food and Drug Administration...
9.
Cluck D, Chastain D, Murray M, Durham S, Chahine E, Derrick C, et al.
Pharmacotherapy
. 2024 Jun;
44(5):360-382.
PMID: 38853601
Treatment options are currently limited for persons with HIV-1 (PWH) who are heavily treatment-experienced and/or have multidrug-resistant HIV-1. Three agents have been approved by the U.S. Food and Drug Administration...
10.
Rebold N, Alosaimy S, Pearson J, Dionne B, Taqi A, Lagnf A, et al.
Infect Dis Ther
. 2024 Mar;
13(3):565-579.
PMID: 38427289
Introduction: Long-acting lipoglycopeptides such as dalbavancin may have utility in patients with Gram-positive bloodstream infections (BSI), particularly in those with barriers to discharge or who require prolonged parenteral antibiotic courses....